Embecta Corp.

Healthcare

NASDAQ:EMBC · NASDAQ Global Select

Market Cap $182.73M Beta 0.81 P/E (TTM) 1.6

$3.10 +0.65%

+$0.02 today

52W Low $2.77High $15.55

Vol 1.54M · Avg 1.92M

EPS (TTM)$1.92

Div Yield14.84%

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-66.23%

Period High

$14.85

Period Low

$2.89

Latest

$3.10

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vir Biotechnology, Inc.

NASDAQ:VIR

$1.45B

CareDx, Inc

NASDAQ:CDNA

$1.19B

Personalis, Inc.

NASDAQ:PSNL

$851.63M

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

$722.58M

Evolent Health, Inc.

NYSE:EVH

$539.91M

Prime Medicine, Inc.

NASDAQ:PRME

$501.21M

Emergent BioSolutions Inc.

NYSE:EBS

$429.28M

Aquestive Therapeutics, Inc.

NASDAQ:AQST

$414.11M

Myriad Genetics, Inc.

NASDAQ:MYGN

$408.96M

SIGA Technologies, Inc.

NASDAQ:SIGA

$309.85M

What is the latest EMBC filing?

The latest filing shown is 4 dated Jun 2, 2026.

How many recent filings does EMBC have?

Intrinsic Alpha currently shows 20 recent filings for EMBC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.